|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.850 USD | -0.26% |
|
-8.19% | +14.69% |
| 07-14 | Ironwood Pharmaceuticals, Inc. Announces Management Changes | CI |
| 05-27 | Ironwood Says US FDA Approves Linzess Use in Children Aged Two Years and Older With Functional Constipation | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Bullish |
| Resistance | 4.77 | 5.39 | 5.23 |
| Spread/Res. | -18.97% | -28.29% | -26.10% |
| Spread/Supp. | +27.14% | +27.14% | +57.25% |
| Support | 3.04 | 3.04 | 2.458 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- IRWD Stock
- Charts Ironwood Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
